Disclaimers

Biovail Corporation provides pharmaceutical and medical products for the treatment and/or prevention of disease. The Company's prescription products are intended only for use under the direction of health-care professionals, and as regulated by government agencies in each of the countries in which it does business. Biovail complies with all regulations concerning distribution, information disclosure and other matters relating to its products.

Material on this Web site is provided for information purposes only. Inclusion of products and information on this site does not imply any official medical advice, recommendation or warranty. Information provided is not a substitute for the advice of an appropriate health professional. This Web site can be accessed from countries around the world, and may contain references to Biovail products and programs that are not available in your country. These references do not imply that Biovail intends to make available such products or programs in your country.

While all attempts will be made to keep this site current, information may become outdated over time, or superceded by subsequent disclosure. This Web site could also include technical or other inaccuracies or typographical errors. Biovail assumes no liability for the accuracy or completeness of, nor any responsibility to update, the information contained on this site. Changes may be periodically added to the information and these changes will be incorporated in new editions of this Web site.

Biovail retains all copyright and other proprietary rights in the contents of this Web site. Elements of this Web site are protected by copyright, trade dress and other laws, and may not be copied or imitated in whole or in part. Nothing shall be construed as granting you any license under any patent, trademark or copyright of Biovail or any third party. Certain portions of this Web site contain information supplied and updated by third parties, or include links to third-party sites. Biovail is not responsible for – and makes no warranty as to the accuracy of such information, or sites.

Biovail claims no ownership in, nor any affiliation with, third-party trademarks or brand names that may appear on this site. Such third-party trademarks are used only to identify the products and services of their respective owners, and no sponsorship or endorsement on the part of Biovail should be inferred from their use. You are not permitted to use the trademarks displayed on this Web site without the prior written consent of Biovail or the third party which may own the trademarks.

Biovail, its affiliates and any of its, or their, directors, officers, employees, or agents shall not, under any circumstances, be liable for direct, consequential, incidental, indirect or special damages, of any kind, or any other damages whatsoever, including without limitation, those resulting from loss of use, data or profits, and whether resulting from the use or inability of use of any contents of this Web site (or a Web site linked to this Web site), or any other cause and even if caused by negligence or if we have been apprised of the likelihood of such damages occurring.

The above limitation, or exclusion, may not apply to you to the extent that applicable law prohibits the limitation or exclusion of liability for incidental or consequential damages. Biovail's total liability to you hereunder shall not, in any event, exceed your online charges for accessing this site.

This Web site (excluding linked sites) is controlled by Biovail Corporation from its offices within the Province of Ontario, Canada. By accessing this Web site, you and Biovail agree that all matters relating to your access to, or use of, this Web site shall be governed by the statutes and laws of the Province of Ontario, without regard to its conflicts of laws principles. You and Biovail also agree, and submit to the exclusive personal jurisdiction and venue of the courts of the Province of Ontario with respect to such matters. Biovail makes no representation that materials on this Web site are appropriate or available for use in other locations, and accessing them from territories where their contents are illegal is prohibited. Those who choose to access this site from other locations do so on their own initiative, and are responsible for compliance with local laws.

The purpose of the Investor Relations section of this Web site is to communicate information to interested investors, and should not be construed as an offer to buy, sell or invest in securities. Visitors should be aware that some statements contained on various pages of this Web site are considered 'forward-looking' under the 1995 Securities Litigation Reform Act.

Caution Regarding Forward-Looking Information and “Safe Harbor” Statement

To the extent any statements made in this release contain information that is not historical, these statements are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and may be forward-looking information under applicable Canadian provincial securities legislation (collectively, “forward-looking statements”). These forward-looking statements relate to, among other things, our objectives, goals, targets, strategies, intentions, plans, beliefs, estimates and outlook, including, without limitation, statements concerning the anticipated commercialization and launch of Aplenzin™ and the potential success of the launch of Aplenzin™, and can generally be identified by the use of words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “may” and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements.

Although Biovail believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, including, but not limited to, factors and assumptions regarding prescription trends, pricing and the formulary and/or Medicare/Medicaid positioning for our products, the competitive landscape in the markets in which we compete, including, but not limited to, the availability or introduction of generic formulations of our products, timelines associated with the development of, and receipt of regulatory approval for, our new products, and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from these expectations include, among other things: the difficulty of predicting FDA and Canadian Therapeutic Products Directorate approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, uncertainties associated with the development, acquisition and launch of new products, reliance on key strategic alliances, contractual disagreements with third parties, availability of raw materials and finished products, the regulatory environment, the expense, timing and uncertain outcome of legal and regulatory proceedings and settlements thereto, market liquidity for our common shares and our satisfaction of applicable laws for the repurchase of our common shares, availability of capital, satisfaction of applicable laws for dividend payments and the ability to generate operating cash flow, the continuation of the recent financial market turmoil, consolidated tax rate assumptions, fluctuations in operating results and other risks detailed from time to time in Biovail’s filings with the Securities and Exchange Commission and the Canadian Securities Administrators, as well as Biovail’s ability to anticipate and manage the risks.